Vontobel Holding Ltd. acquired a new position in Oscar Health, Inc. (NYSE:OSCR – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 17,004 shares of the company’s stock, valued at approximately $524,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Assenagon Asset Management S.A. increased its holdings in shares of Oscar Health by 107.5% during the 3rd quarter. Assenagon Asset Management S.A. now owns 2,589,708 shares of the company’s stock valued at $79,867,000 after purchasing an additional 1,341,716 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Oscar Health by 22.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company’s stock valued at $48,078,000 after purchasing an additional 759,837 shares during the period. Wedge Capital Management L L P NC purchased a new stake in Oscar Health during the second quarter worth $32,855,000. Bank of America Corp DE boosted its holdings in Oscar Health by 205.1% during the first quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock worth $32,808,000 after buying an additional 1,922,732 shares in the last quarter. Finally, Wellington Management Group LLP boosted its holdings in Oscar Health by 65.6% during the second quarter. Wellington Management Group LLP now owns 603,675 shares of the company’s stock worth $17,217,000 after buying an additional 239,109 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.
Insider Buying and Selling
In other Oscar Health news, insider Adam Mcananey sold 9,092 shares of the company’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $285,943.40. Following the completion of the transaction, the insider directly owned 209,004 shares in the company, valued at approximately $6,573,175.80. This represents a 4.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 31,422 shares of the company’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $988,221.90. Following the transaction, the director owned 449,444 shares of the company’s stock, valued at approximately $14,135,013.80. This trade represents a 6.53% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 874,451 shares of company stock worth $26,761,671 in the last 90 days. 22.64% of the stock is owned by insiders.
Oscar Health Stock Up 3.5%
Oscar Health stock opened at $33.68 on Wednesday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09. The stock has a market capitalization of $10.39 billion, a PE ratio of 24.05, a price-to-earnings-growth ratio of 0.36 and a beta of 2.47. The business has a 50 day simple moving average of $31.69 and a 200-day simple moving average of $27.02. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $35.01.
Oscar Health (NYSE:OSCR – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%. The firm had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.73 billion. During the same quarter last year, the firm posted ($0.89) EPS. The business’s revenue was up 70.4% on a year-over-year basis. On average, analysts anticipate that Oscar Health, Inc. will post 1.83 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several analysts recently commented on OSCR shares. Weiss Ratings upgraded shares of Oscar Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Barclays upped their price objective on shares of Oscar Health from $39.00 to $49.00 and gave the stock an “overweight” rating in a research report on Thursday, September 17th. Stephens reiterated an “equal weight” rating and issued a $34.00 price objective on shares of Oscar Health in a research report on Thursday, September 17th. Wells Fargo & Company increased their target price on shares of Oscar Health from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research note on Thursday, August 13th. Finally, Piper Sandler restated an “overweight” rating and set a $48.00 target price on shares of Oscar Health in a research report on Thursday, September 17th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $34.90.
Read Our Latest Report on OSCR
Oscar Health Company Profile
Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.
Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.
Recommended Stories
- Five stocks we like better than Oscar Health
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR – Free Report).
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.
